ArticleAmerican journal of cancer research2018

Blocking LLT1 (CLEC2D, OCIL)-NKRP1A (CD161) interaction enhances natural killer cell-mediated lysis of triple-negative breast cancer cells.

Armando M Marrufo et al.PubMed ↗Full text ↗

No numbers read from the abstract.